Doi.org/10.1016/j.dld.2014.11.015
Revision as of 06:22, 18 August 2022 by 187.21.138.9 (talk) (Created page with "== Target Article == Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial; Shihui Chen et al. ; Digestive and Liver Disease; 2014; https://doi.org/10.1016/j.dld.2014.11.015 == Article providing comments == Comment on “Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial” b...")
Target Article[edit | edit source]
Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial; Shihui Chen et al. ; Digestive and Liver Disease; 2014; https://doi.org/10.1016/j.dld.2014.11.015
Article providing comments[edit | edit source]
Comment on “Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial” by Shihui Chen et al. [Dig. Liver Dis. 2015;47:226–32]; Rotman, Yaron; ; Digestive and Liver Disease; 2015-12-01 https://doi.org/10.1016/j.dld.2015.08.011
Summary[edit | edit source]
Note: Opened to append information.